INTRODUCTION {#sec1}
============

Dopamine is the hormone of "motivation, thrill and adventure seeking" \[[@cit0001]\]. The influence of dopamine is associated with making so called "risky decisions". The next element that should be acknowledged as important is the so called "mesolimbic reward system" which mediates the reward psychopharmacology response to physical effort or other factors. Dopamine, described as a "pleasure neurotransmitter," is functionally connected with the "pleasure center," located in the ventral tegmental area of the brain in which there are neurons of the dopaminergic system and nucleus accumbent \[[@cit0002]\]. Hence, the system seems to be one of the key factors in starting and continuing training. It seems that the interactions between genetically conditioned temperament and environmentally conditioned character, are factors influencing will to participate in and continue with sport training, which consequently affect achievement of success in this area \[[@cit0003],[@cit0004]\]. Hence, ontogenetic differences result from the modulatory influence of the neurotransmitter system on expression of particular personality traits among others. This example of such modification could be a shortage of dopamine that results in significantly influencing "novelty-seeking" behaviors expressed in the form of constantly searching for new "thrills". The effect is functional modification of dopaminergic system \[[@cit0005],[@cit0006],[@cit0007],[@cit0008]\]. Another factor which exerts influence by modulating the dopaminergic pathway, and consequently sporting achievement, is visual perception, which is probably one of the key determinants in combat sports. Dopamine, which is a chemical analogue of light, affects the paracrine neurotransmitter in the retina, whereas receptors D2 and D4 of photoreceptor cells control illumination-related processes, among which melatonin biosynthesis, opsin expression in cone cells or the level of cAMP inside receptors \[[@cit0009]\] are included.

Personality significantly influences behavior, life-style and also the maintenance of healthy habits in a lifetime. Current research concerning personality concentrates on the model that is constructed of the so called Big Five \[[@cit0010],[@cit0011],[@cit0012],[@cit0013]\], which consists of: Openness, Conscientiousness, Extraversion, Agreeableness and Neuroticism domains. These 5 traits isolate differences among people which influence emotions, motivation and cognition \[[@cit0014]\]. Currently, to analyze these personality traits, the NEO personality inventory (NEO-FFI) is employed.

The high novelty-seeking or 'risk-taking' personality trait was previously correlated with genetic variants within genes encoding dopamine receptors \[[@cit0015]\]. These dopamine receptors, including D2 and D4 receptor subtypes, are involved in dopamine neurotransmission and may modulate memory, behaviour and executive function \[[@cit0016]\]. It has also been suggested that dopamine neurotransmission is connected with novelty-seeking \[[@cit0017],[@cit0018]\], which is defined as "excitement to novel stimuli" in relation with dependence \[[@cit0019],[@cit0020]\] and relapse \[[@cit0021]\]. Also, extraversion is a trait connected with the functioning of the dopaminergic system. As dual research shows, the traits are related with genetics in different ranges -- from 25% to 61% \[[@cit0021], [@cit0022]\]. Both novelty-seeking and extraversion are correlated with receptor 4 of the dopamine gene (*DRD4*) as indicated in research on healthy \[[@cit0023]\] and research dependent \[[@cit0024]\] subjects. However, other research does not seem to confirm this association \[[@cit0025]\].

The *DRD4* gene encodes the dopamine D4 receptor and is expressed in the cognitive and emotional areas of the limbic system and is located on chromosome 11 (locus p15.5). A variable number of tandem repetitions (VNTR) located in the 3rd exon is one of the most frequently investigated polymorphisms of the gene. To date, association has been demonstrated for 2 of the 10 repeated 48bp sequence variants, showing influence on length of the third intracellular loop receptor D4. Interestingly, polymorphic variants influence the expression of these genes in a different manner \[[@cit0026]\]. Asghari \[[@cit0027]\], in his work, indicates diversified sensitivity in relation to endogenous dopamine depending on the length of the variant coding for the particular receptor. Dopamine transporter gene *DAT1*, which is another key element of the dopaminergic system, is located in chromosome 5 (p15.3). The most frequently investigated variant is the VNTR polymorphism located in 3' UTR region. The 40bp sequence of 3 to 13 repetitions was identified, however, the most frequently occurring variants had 9 or 10 repeated sequences \[[@cit0028]\]. Nevertheless, contradictory reports concerning polymorphic variants and *DAT1* transcription level were also observed in this case \[[@cit0029],[@cit0030]\].

The goal of the present study was to investigate the personality traits in elite combat athletes and healthy controls with respect to variable number of tandem repeats (a 48 bp unit) in the third exon of the *DRD4* gene.

MATERIALS AND METHODS {#sec2}
=====================

Materials {#sec2.1}
---------

The study was conducted among healthy (non-dependent and non-psychosis) 200 Polish male combat athletes aged 22.9 ± 4.2 (judo, n = 51; wrestling, n = 38; boxing, n = 50, kickboxing, n = 32; karate, n = 29). All of them were ranked in the top 10 nationally in their respective disciplines. The study population included 16 athletes classified as 'top-elite' (gold medalists in the World and European Championships, World Cups or Olympic Games) and 68 athletes classified as 'elite' (silver or bronze medalists in the World and European Championships, World Cups or Olympic Games). The others (n=69) were classified as 'sub-elite' (participants in international competitions, with no less than 8 years experience). Various methods were used to obtain the samples, including targeting national teams and providing information to national coaching personnel and athletes attending training camps.

Controls included 102 unrelated, healthy (non-dependent and non-psychosis) Polish male volunteers aged 21.6±2.6. All athletes and controls were Caucasian to reduce the possibility of racial gene skewing and to overcome any potential problems due to population stratification.

Ethical approval {#sec2.2}
----------------

The procedures followed in the study were conducted in accordance with the principles of the World Medical Association Declaration of Helsinki and were approved by the Bioethics Committee for Clinical Research at the Regional Medical Chamber in Gdansk, Poland. All participants were provided with an information sheet concerning study particulars, including the purpose of the study and the procedures involved, in addition to the possible risks and benefits associated with participation. All participants provided written informed consent to genotyping with the understanding that it was anonymous and that the obtained results would be confidential.

Methods {#sec2.3}
-------

### Personality Traits {#s2c1}

All participants were tested using the NEO Five-Factor Personality Inventory (NEO-FFI) and, the State-Trait Anxiety Inventory (STAI) questionnaires. The results of these were both given on the sten scale.

The NEO Five Factor Inventory questionnaire is used to diagnose personality traits, which are included in the five-factor model defined by the Big Five model (neuroticism, extraversion, openness, conscientiousness and agreeableness). The questionnaire consists of 60 statements (of self-reported character), which require the participant to examine one's attitude toward one's own self. The Anxiety Inventory (STAI) questionnaire is used to examine anxiety, which is understood as conditionally and transiently conditioned condition of the individual and anxiety, understood as a relatively constant personality trait. The STAI questionnaire consists of two independent subscales, each of which contains 20 statements, one (X-1) measures anxiety-state and the other (X-2) measures an anxiety-trait.

Genetic analyses {#sec2.4}
----------------

For the genetic assays, blood was collected into tubes with EDTA (anticoagulant). Data Collection Genomic DNA from peripheral blood leukocytes was extracted using a High Pure Polymerase Chain Reaction (PCR) Template Preparation extraction kit (Roche Diagnostics, Mannheim, Germany). The extraction was performed according to the manufacturer's instructions. DNA sample were stored at 4°C for further analysis.

The genomic DNA was isolated from venous blood according to standard procedures. Samples were genotyped using the PCR method. The *DRD4* genotypes were grouped based on the presence of the short (2--5 repeat) and long (6--11 repeat) variants. Genotyping was performed using the PCR-VNTR method, using primers: F: 5 0 -GCG ACT ACG TGG TCT ACT CG 3 0, R: 5 0 -AGG ACC CTC ATG GCC TTG 3 0; in the final volume of 25 μL PCR mix per reaction, with l00 ng genomic DNA, 10 pmol of primers, 50 mM KCl, 10 mM TrisHCl, 1.5 mM MgCl2, 200 μM dATP, dCTP, dTTP, dGTP and 0.8 U of the Tag polymerase. Conditions for reaction: 3 min. of initial denaturation in 95°C, cycling 30 s. of denaturation in 95°C, 1 min. of primers hybridization in 63°C and 30 s. of elongation in 72°C, repeated in 35 cycles, 5 min. of final elongation in 72°C. The amplified products were visualized using ethidium bromide stained gel electrophoresis (3% agarose) and UV photography. The products ranged from 379 bp (2 repeats) to 811 (11 repeats). The products were divided into 2 groups: short alleles (S, 2--5 repeats) and long alleles (L, 6--11 repeats).

Statistical analysis {#sec2.5}
--------------------

Concordance between the genotype frequency distribution and Hardy-Weinberg equilibrium (HWE) was tested with the HWE software (<http://www.oege.org/software/hwe-mr-calc.html>) \[[@cit0031]\]. *DRD4* genotype frequencies between control subjects and cases were tested using Chi square test. The relationship between DRD4 variant, group assignment (elite athletes vs controls) and NEO Five Factor Inventory (NEO-FFI) or STAI sten scores were analyzed using 2 x 3 factorial ANOVA. The Tukey HSD post-hoc tests were conducted to determine if the interaction term was significant. All computations were performed using STATISTICA 13 (Tibco Software Inc, Palo Alto, CA, USA) for Windows (Microsoft Corporation, Redmond, WA, USA).

RESULTS {#sec3}
=======

The observed *DRD4* Ex3 VNTR polymorphism frequencies did not differ from expectations based on Hardy-Weinberg theorem, neither in the elite athletes ([Table 1](#t0001){ref-type="table"}, p=0.094), nor in the control group ([Table 2](#t0002){ref-type="table"}, p=0.192). There were no significant differences between cases and controls with respect to genotypes (p=0.090) and alleles (p=0.669) ([Table 3](#t0003){ref-type="table"}).

###### 

Hardy-Weinberg's law for the athletes subjects.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Hardy-Weinberg equilibrium calculator including analysis for ascertainment bias   Observed (Expected)             Test χ^2^                      
  --------------------------------------------------------------------------------- --------------------- --------- ----------------------- ------ --------
  DRD4 Ex3                                                                          l/l                   6 (10.1   s allele freq = 0.78\   2.80   \>0,05
                                                                                                                    l allele freq = 0.22           

  s/l                                                                               78 (69.7)                                                      

  s/s                                                                               116 (120.1)                                                    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Hardy-Weinberg's law for the control subjects.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Hardy-Weinberg equilibrium calculator including analysis for ascertainment bias   Observed (Expected)               Test χ^2^                    
  --------------------------------------------------------------------------------- --------------------- ----------- ---------------------- ----- --------
  DRD4 Ex3                                                                          s/l                   28 (32.1)   s allele freq = 0.8\   1.7   \>0,05
                                                                                                                      l allele freq = 0.2          

  s/s                                                                               68 (65.9)                                                      

  l/l                                                                               6 (3.9)                                                        
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Frequency of genotypes and alleles of the *DRD4 Ex3* genes polymorphisms in athletes and in controls.

  Group       DRD4 Ex3                                     
  ----------- ---------- -------- -------- -------- ------ --------
  Athletes    78         116      6        310             90
  N=200       (0.39)     (0.58)   (0.03)   (0.78)          (0.22)
  Control     28         68       6        164             40
  N=102       (0.27)     (0.67)   (0.06)   (0.80)          (0.20)
  *χ*2                   4.81                       .67    
  *p value*              .090                       .413   

p-statistical significance χ2 test, N- number of subjects

Significant between-group differences are marked in bold print.

The results of 2x3 factorial ANOVA of the NEO Five-Factor Personality Inventory (NEO-FFI) and the State-Trait Anxiety Inventory (STAI) sten scales are summarized in [Table 4](#t0004){ref-type="table"}. We found a significant result when comparing groups (elite athletes vs controls) for Openness (F1,296=16.3, p=0.00007) and Conscientiousness (F1,296=10.3, p=0.001), accounting for 5.2% and 3.4% of variance, respectively. In addition to those findings, we found group x *DRD4* genotype interactions: for Openness ([Figure 1](#f0001){ref-type="fig"}, F2,296=5.01, p=0.007) and Conscientiousness ([Figure 2](#f0002){ref-type="fig"}, F2,296=4.18, p=0.016) responsible for 3.3% and 2.7% phenotypic variation, respectively. Post-hoc analysis is shown in [Table 5](#t0005){ref-type="table"}.

###### 

STAI and NEO Five Factor Inventory results between healthy control and athletes.

  ---------------------------------------------------------------------------------------------------------------
  STAI / NEO Five Factor Inventory/ (sten scale)   Athletes (N = 200)   Control (N = 102)   t\        Cohen's d
                                                                                            p value   
  ------------------------------------------------ -------------------- ------------------- --------- -----------
  STAI ST                                          4.90± 2.22           4.73±2.14           .688      .08

  STAI C                                           5.28±2.37            5.20±2.00           .848      .04

  Neuroticism/scale                                4.84±2.30            4.82±1.72           .967      .01

  Extraversion/scale                               6.20±1.88            6.14±1.78           .864      .03

  Openness/scale                                   4.42±1.62            4.63±1.75           .538      .12

  Agreeability/scale                               5.18±2.13            5.51±1.88           .411      .16

  Conscientiousness/scale                          7.18±1.92            5.98±1.79           .002      .65
  ---------------------------------------------------------------------------------------------------------------

p-statistical significance t-Student's test, N- number of subjects

Significant between-group differences are marked in bold print.

###### 

Differences in DRD4 Ex3 and STAI /NEO Five Factor Inventory between healthy control subjects and athletes.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  STAI /NEO Five Factor Inventory (sten scale)                                                DRD4 Ex3      Main Effects ANOVA                                                                                             
  ---------------------------------------------- ------------------------------ ------------- ------------- -------------------- ------------- -------------------- --------------- --------------------------- ---------- -----------
  STAI ST                                        4.90 ± 2.22                    4.72 ± 2.14   4.45 ± 2.73   4.61 ± 2.65          3.75 ± 2.18   F5,296=.389\         **intercept**   **F~1,296~=223 (p=.000)**   **.430**   **1.000**
                                                                                                                                               p=.865\                                                                     
                                                                                                                                               R2=.007                                                                     

  sport/control                                  F1,296=.0003 (p=.987)          1e-6          .050                                                                                                                         

  DRD4 Ex3                                       F2,296=.65 (p=.525)            .004          .158                                                                                                                         

  sport/control x DRD4 Ex3                       F2,296=0.12 (p=.883)           .0008         .069                                                                                                                         

  STAI C                                         5.28 ± 2.37                    5.20 ± 2.00   4.93 ± 2.56   4.97 ± 2.91          4.25 ± 2.18   F5,296=.557\         **intercept**   **F~1,296~=252 (p=.000)**   **.460**   **1.000**
                                                                                                                                               p=.733\                                                                     
                                                                                                                                               R2=.009                                                                     

  sport/control                                  F1,296=.34 (p=.560)            .001          .089                                                                                                                         

  DRD4 Ex3                                       F2,296=.31 (p=.735)            .0002         .099                                                                                                                         

  sport/control x DRD4 Ex3                       F2,296=.08 (p=.922)            .0006         .062                                                                                                                         

  NEO FFINeuroticism/scale                       4.84 ± 2.30                    4.82 ± 1.72   4.63 ± 2.62   4.16 ± 2.44          3.25 ± 2.60   F5,296=1.14\         **intercept**   **F~1,296~=223 (p=.000)**   **.430**   **1.000**
                                                                                                                                               p=.338\                                                                     
                                                                                                                                               R2=.019                                                                     

  sport/control                                  F1,296=.04 (p=.837)            .0001         .054                                                                                                                         

  DRD4 Ex3                                       F2,296=2.08 (p=.127)           .014          .426                                                                                                                         

  sport/control x DRD4 Ex3                       F2,296=0,17 (p=.843)           .001          .076                                                                                                                         

  NEO FFIExtraversion/scale                      6.20 ± 1.88                    6.14 ± 1.78   5.44 ± 2.64   5.40 ± 2.39          6.67 ± 3.03   F5,296=1.02\         **intercept**   **F~12965~=473 (p=.000)**   **.615**   **1.000**
                                                                                                                                               p=.406\                                                                     
                                                                                                                                               R2=.017                                                                     

  sport/control                                  F1,296=1.18 (p=.278)           .004          .192                                                                                                                         

  DRD4 Ex3                                       F2,296=1.57 (p=.209)           .011          .333                                                                                                                         

  sport/control x DRD4 Ex3                       F2,296=0.13 (p=.878)           .0009         .070                                                                                                                         

  NEO FFIOpenness /scale                         4.42 ± 1.62                    4.63 ± 1.75   4.57 ± 2.39   4.01 ± 2.01          3.50 ± 2.54   **F~5,296~=4.48**\   **intercept**   **F~1,296~=331 (p=.000)**   **.528**   **1.000**
                                                                                                                                               **p=.0006**\                                                                
                                                                                                                                               **R^2^=.070**                                                               

  sport/control                                  **F~1,296~=16.3 (p=.00007)**   **.052**      **.981**                                                                                                                     

  DRD4 Ex3                                       **F~2,296~=3.80 (p=.023)**     **.025**      **.689**                                                                                                                     

  sport/control x DRD4 Ex3                       **F~2,296~=5.01 (p=.007)**     **.033**      **.812**                                                                                                                     

  NEO FFIAgreeability/scale                      5.18 ± 2.13                    5.51 ± 1.88   5.03 ± 2.64   5.56 ± 2.56          5.00 ± 1.86   F5,296=0.684\        **intercept**   **F~1,296~=358 (p=.000)**   **.548**   **1.000**
                                                                                                                                               p=.636\                                                                     
                                                                                                                                               R2=.011                                                                     

  sport/control                                  F1,296=.005 (p=.941)           .00002        .051                                                                                                                         

  DRD4 Ex3                                       F2,296=1.66 (p=.192)           .011          .349                                                                                                                         

  sport/control x DRD4 Ex3                       F2,296=1.06 (p=.853)           .001          .074                                                                                                                         

  NEO FFIConscientiousness/scale                 7.18 ± 1.92                    5.98 ± 1.79   6.10 ± 2.46   6.23 ± 2.59          6.33 ± 2.46   **F~5,296~=6.85**\   **intercept**   **F~1,296~=569 (p=.000)**   **.658**   **1.000**
                                                                                                                                               **p=.000005**\                                                              
                                                                                                                                               **R^2^=.104**                                                               

  sport/control                                  **F~1,296~=10.3 (p=.001)**     **.034**      **.892**                                                                                                                     

  DRD4 Ex3                                       F2,296=0.14 (p=.868)           .0009         .072                                                                                                                         

  sport/control x DRD4 Ex3                       **F~2,296~=4.18 (p=.016)**     **.027**      **.733**                                                                                                                     
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

![The group (elite athletes vs healthy controls) x *DRD4* Ex3 polymorphism interaction for the NEO Five Factor Inventory scale of Openness.](JBS-36-85457-g001){#f0001}

![The group (elite athletes vs healthy controls) x *DRD4* Ex3 polymorphism interaction for the NEO Five Factor Inventory scale of Conscientiousness.](JBS-36-85457-g002){#f0002}

DISCUSSION {#sec4}
==========

In the present study, we demonstrated elite status in combat sports x *DRD4* genotype interactions in two domains of the five-factor model of personality: Openness and Conscientiousness. Specifically, Openness differed between *DDR4* Ex3 VNTR genotypes, but only in the elite athletes (1.33±0.82 vs 4.36±2.36, for the L/L and S/L genotype, respectively, p=0.031), whereas Conscientiousness, although not statistically different between *DRD4* genotypes in both elite athletes and healthy controls, was significantly higher in the elite athletes compared with controls, especially in the S/S homozygotes (6.98±2.34 vs 4.96±2.49, p=0.00003).

In 1996, two independent papers showed an association between dopaminergically modulated personality trait novelty seeking and the *DRD4* gene \[[@cit0018],[@cit0032]\]**.** The higher scores of novelty seeking assessed by Tridimensional Personality Questionnaire were found in carriers of the 7-repeat allele and those findings were subsequently confirmed by others \[[@cit0033],[@cit0034]\]. Interestingly, in the present study, we found that the elite combat athletes homozygous for the L allele (defined as the 6-11 repeats of a 48 bp segment) had significantly lower Openness scores compared with S/L heterozygotes. It is difficult to compare our findings with previous observations, as we did not assess the novelty seeking, nor did we predict it by means of correlation (multiple regression models) between novelty seeking and NEO-FFI \[[@cit0035]\]. However, given the link between novelty seeking and openness to experience (and extraversion) \[[@cit0036]\]) our results may seem contradictory to previous findings that suggest an association between novelty seeking and the long allele of the *DRD4* VNTR \[[@cit0011],[@cit0032],[@cit0033]\]. On the other hand, the correlation between novelty seeking and NEO-EFI openness domain may not be straightforward. According to Gocłowska et al**.** \[[@cit0036]\], "both openness and extraversion are linked to novelty in a unique way, with each of the other traits explaining a somewhat different portion of variance in novelty seeking behavior". Also, many recent studies have not found any associations between the *DRD4* exon 3 polymorphism and novelty seeking or extraversion \[[@cit0037].[@cit0038]\]**.** A recent meta-analysis of studies of the association between the *DRD4* VNTR and *DRD4* promoter polymorphism (-521 C/T) and several approach-related traits including novelty seeking, extraversion and impulsivity revealed that only a promoter variant may be associated with novelty seeking and impulsivity \[[@cit0039]\]. Moreover, in a genomewide association study of the FFM of personality traits in young Korean women, none of the NEO-FFI major factors were associated with the *DRD4* gene \[[@cit0040]\]. Benjamin et al. \[[@cit0032]\] reported that the presence of the 7-repeat allele was also associated with lower NEO Conscientiousness scores. However, subsequent studies failed to confirm this initial finding \[[@cit0025],[@cit0034]\]. Moreover, Paterson et al. \[[@cit0041]\] pointed out some methodological flaws in the original association studies. In the present study we did not find any *DRD4* VNTR genotype dependent diferences in NEO Conscientiousness scores in the elite athletes or control individuals. However, this personality domain was significantly higher in the athletes compared with control individuals, yet the difference was evident only in carriers of the S/S genotype. It is not clear whether this is only a statistical phenomenon or a reflection of true biological interaction. The relationship between personality and exercise capacity has long been of interest to sport psychologists \[[@cit0042]\]. Elite athletes competing at the national and international level were found to have lower levels of neuroticism than non-elite athletes, whereas the level of conscientiousness and agreeableness was higher \[[@cit0043]\]. In another study, athletes scored higher than non-athletes for conscientiousness, but other personality traits did not differ significantly between the groups \[[@cit0042]\]**.** Thus, although our study is similar to previous studies with respect to the association between Conscientiousness and elite status, it is not clear whether the S allele, linked to higher scores of Conscientiousness \[[@cit0032]\], plays any role in the observed interaction pattern.

Studies investigating the *DRD4* variants with respect to personality dimensions in a specialized cohort of athletes are scant \[[@cit0044],[@cit0045],[@cit0046]\]. In 2013, Thomson et al. \[[@cit0046]\] reported a significant association between the -521 C/T (rs1800955) polymorphism in the promoter region of the *DRD4* and sport-specific sensation seeking in a high-risk sport population (skiers and snowboarders). Interestingly, another study by the same authors, in which five polymorphisms were investigated (21106T/C, 2906T/C, 2809G/A, 2291C/T, 120-bp duplication) in the promoter region of the *DRD4* in a cohort of skiers and snowboarders, failed to reproduce the previous finding of association between the *DRD4* and sensation seeking \[[@cit0047]\]. In a recent study, Abrahams et al. \[[@cit0048]\] investigated associations of *DRD2* and *DRD4* genotypes with concussion susceptibility and personality in rugby players . The authors found the association between the -521 C/T *DRD4* variant and concussion susceptibility as well as socially detached behaviour.

CONCLUSIONS {#sec5}
===========

Engaging in high-risk sport (e.g. snowboarding, parachuting, martial arts) may be associated with several personality characteristics. In the present study, we found an interaction between the dopamine D4 receptor gene VNTR polymorphism and athletic status in two major NEO-FFI factors: Openness and Conscientiousness. The *DRD4* exon 3 polymorphism may be associated with the NEO Openness and Conscientiousness domains in martial arts athletes, thereby modulating athletes' predisposition to participate in high risk sport. As a majority of personality traits have been linked to genetic factors, behavioral genetic studies and personality genetics represent a new promising area of research aimed at obtaining a better understanding of athletic motivation and behavior.
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